Abstract:Objective:To explore the genetic mutation, clinical characteristics, diagnosis and treatment of patients with hereditary coagulation factor FⅪ deficiency.Methods:On August 10 and October 30, 2020, two patients with hereditary FⅪ deficiency who were admitted at Department of Hematology, West China Hospital of Sichuan University were selected as research subjects. Patients 1 and 2 were numbered according to visiting time. Diagnosis was made according to coagulation function test and results of gene sequencing F11 gene.Clinical observation or symptomatic treatment were performed according to clinical bleeding symptom and severity. Novel mutations were confirmed by retrieving Human Gene Mutation database (HGMD), Single Nucleotide Polymorphism Database (dbSNP) and PubMed database. Pathogenicity of the novel missense mutation was predicted by computational software of Mutation Taster, Polyphen-2, and PROVEAN. Follow-up of patients was conducted until February 28, 2021. Clinical manifestations and process of diagnosis and treatment of two patients were analyzed retrospectively. China National Knowledge Infrastructure database, Wanfang Data Knowledge Service Platform, PubMed database were searched for the same and similar case reports as F11 genetic mutation in this study.Retrieval time was from database inception to February 28, 2021. Types of genetic mutations and clinical manifestations related to patients in this study were summarized.This study meeted the requirements of the World Medical Association Declaration of Helsinki revised in 2013. Informed consent of patients was obtained from pateints. Results:① Results of medical history: patient 1, a 24 years old man, was admitted due to " hematoma after soft tissue trauma in left thigh and preoperative examination revealed coagulation dysfunction" and did not complain of significant discomfort.Patient 2, a 32 years old woman, was admitted due to " pre-pregnancy physical examination found prolonged activated partial thromboplastin time (APTT)" and complained of occasional ecchymosis.② Results of related laboratory examination: APTT, prothrombin time (PT) and FⅪ activity (FⅪ∶C) of patient 1 were 97.9 s, 11.9 s and 0.6%, while patient 2 were 95.4 s, 12.5 s, and 1.2%, respectively. ③ Results of DNA sequencing: patient 1 had a compound heterozygous missense mutation of F11 gene at c. 149G>T(p.Cys50Phe) and c. 1204C>T (p.Gln402Ter), while patient 2 had a homozygous deletion of F11 gene at c. 1058delA (p.Asn353ThrfsTer18). ④ F11 gene missense mutation at c. 149G>T(p.Cys50Phe) and deletion c. 1058delA(p.Asn353ThrfsTer18) were two novel mutations and both were pathogenic.⑤Results of treatment and follow-up: two patients received clinical observation. At end of follow-up, general condition of the patients was good. ⑥ Results of literatures review: among 10 patients reported in 6 relevant literatures, there were 1, 3, 6 patients caused by heterozygous nonsense mutation of c. 1204C>T(p.Gln402Ter), nonsense mutation of c. 1202C>T(p.Trp401Ter) adjacent to c. 1204C>T (p.Gln402Ter) and missense mutations near the position of c. 149G>T(p.Cys50Phe), respectively. Conclusions:Two novel mutations of hereditary FⅪ deficiency namely a missense mutation at c. 149G>T(p.Cys50Phe) and a deletion at c. 1058delA(p.Asn353ThrfsTer18) of F11 gene were reported in this study. Both of the two mutations related to decrease of FⅪ∶C.

Thrombin generation test in estimating the clinical bleeding of patients with inherited coagulation factor deficiencies

Use of Thrombin Generation Test in Hemophilia Patients

Genetic analysis of patients with hereditary coagulation factor Ⅺ deficiency and literatures review

[Congenital Factor X Deficiency: a Retrospective Analysis of 11 Cases].

[Congenital factor VII deficiency: a retrospective analysis of 43 cases].

Six novel missense mutations causing factor X deficiency and application of thrombin generation test.

Clinical Analysis of Hereditary Coagulation Factorⅴdeficiency

Analysis of Clinical Phenotype and Genotype of Two Hereditary Coagulation Factor Ⅻ Deficiency

Bleeding Symptoms in Pediatric Patients with Congenital FVII Deficiency and Correlation to Thrombin Generation Assay Parameters: A Single-Center Retrospective Analysis

[The Application of Thrombin Generation Tests to Warfarin Anticoagulation Monitoring].

The effect of factor XIa on thrombin and plasmin generation, clot formation, lysis and density in coagulation factors deficiencies

Laboratory Diagnosis of a Pedigree with Inherited Coagulation Factor V Deficiency

Congenital coagulation factor V deficiency with intracranial hemorrhage

[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].

[Analysis of Phenotype and Genotype in Four Chinese Pedigrees with Inherited Coagulation Factor V Deficiency.].

Assessment of activities or plasma levels of coagulation/anticoagulation factors in patients with venous thromboembolism

Molecular analysis of the discrepancy between the genotypes and phenotypes in a inherited coagulation factor Ⅶ deficiency.

Correlation between Phenotype and Coagulation Factor Activity Level in Rare Bleeding Disorders: A Systematic Review

Molecular Genetics and Clinical Features in 10 Patients with Hereditary F VII Deficiency

Establishment the clot waveform analysis reference intervals for four coagulation parameters and clinical application study

Genetic diagnosis and phenotype analysis for 9 patients with hereditary coagulation factor Ⅶ deficiency